Company Analysis

PMGC Holdings Inc. (ELAB)

Nasdaq: ELAB · Pharmaceutical Preparations · Newport Beach, CA · filing with the SEC since 2021
Grade3.7
◀ Past 3.8● Present 2.6▶ Future 4.5
2 est.

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022
Report filedMar 30, 2026Mar 28, 2025Mar 29, 2024·
Revenue590,084·1,712,595766,277
Cost of revenue404,770·578,015318,968
Gross profit185,314·1,134,580447,309
Research and development147,010104,6547,410r228,747
Sales and marketing··660,291192,863
General and administrative2,238,6601,092,576347,653r1,019,708
Total operating expenses7,067,2623,663,5661,140,958r2,238,350
Total costs and expenses··4,900,791·
Interest expense257,630735,19719,5252,629
Interest and investment income118,03012,8915,5647,702
Other income (expense), net··-535,306·
Total non-operating income (expense)··-3,766,211-1,791,041
Income before income taxes-7,749,768-4,016,714··
Income tax expense30,972···
Income from continuing operations-7,780,740-4,016,714-1,656,739·
Income from discontinued operations32,927-2,229,023-2,644,778·
Net income-7,747,813-6,245,737-4,301,517-1,800,268
Earnings per share, basic··-33.60b-15.876b
Earnings per share, diluted··-33.60b-15.876b
Weighted average shares, basic20,352947r91,000rb113,439b
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-84 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:Revenues
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
us-gaap:InterestIncomeOther
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Income from continuing operations profit from the businesses it keepsus-gaap:IncomeLossFromContinuingOperations
Income from discontinued operations profit or loss from businesses it sold or closedus-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
SI Assistanton ELAB · research, not advice